Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sernova Corp SEOVF


Primary Symbol: T.SVA

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

Recent & Breaking News (TSX:SVA)

Sernova Receives Patent Allowance for Therapeutic Cell Immune Protection Technology

Marketwired June 24, 2013

Sernova Provides Corporate Update and Results of 2013 Annual General Meeting

Marketwired May 9, 2013

Sernova Provides Corporate Update and Results of 2013 Annual General Meeting

Marketwired May 9, 2013

Sernova Issues Additional Finder Warrants, Cancels Options

Marketwired April 5, 2013

Sernova Issues Additional Finder Warrants, Cancels Options

MarketWire Canada April 5, 2013

Sernova Awarded Funding to Optimize Its Sertolin(TM) Local Therapeutic Cell Anti-Rejection Technology for the Treatment of Chronic Diseases

MarketWire Canada March 25, 2013

Sernova and Centre for Commercialization of Regenerative Medicine Partner to Treat Chronic Diseases

MarketWire Canada February 28, 2013

Sernova Completes Non-Brokered Private Placement

Marketwired February 19, 2013

Sernova Announces Non-Brokered Private Placement

Marketwired January 21, 2013

Junior exploration stock pops on graphite claims acquisition

Sean Mason May 2, 2012

Sernova puts focus on diabetes

Richard (Rick) Mills April 4, 2012

Sernova Completes First Tranche of Non-Brokered Private Placement

Press Releases February 29, 2012

Biotech firm focuses on diabetes

Richard (Rick) Mills December 5, 2011

Sernova, Diabetes and cell therapy

Richard (Rick) Mills March 15, 2011

Sernova tackles Diabetes

Richard (Rick) Mills September 24, 2010

Two for Diabetes

Richard (Rick) Mills May 27, 2010

Stockhouse @ the Bell: Stocks shrug off dismal jobs data

Stockhouse Editorial December 5, 2008